Literature DB >> 23062898

Can the level of CD52 expression on Sézary cells be used to predict the response of Sézary syndrome to alemtuzumab?

Iolanda Conde Fernandes, Marta Gonçalves, Maria dos Anjos Teixeira, Cristina Gonçalves, Jorge Coutinho, Manuela Selores, Rosário Alves, Margarida Lima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23062898     DOI： 10.1016/j.jaad.2012.05.010

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

1.  Mutation in PIGA results in a CD52-negative escape variant in a Sézary syndrome patient during alemtuzumab treatment.

Authors:  Constantijn J M Halkes; Willem H Zoutman; Leslie van der Fits; Inge Jedema; Maarten H Vermeer
Journal:  J Invest Dermatol       Date:  2014-11-28       Impact factor: 8.551
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.